Icon

NAMZARIC (nda206439)- (10MG;14MG,10MG;28MG,10MG;7MG,10MG;21MG)

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE ABBVIE
10MG;14MG,10MG;28MG,10MG;7MG,10MG;21MG
Yes Yes
2029-Dec-05 Expired
None None
None No
NAMZARIC is a combination of memantine hydrochloride, an NMDA receptor antagonist, and donepezil hydrochloride, an acetylcholinesterase inhibitor, indicated for the treatment of moderate to severe dementia of the Alzheimer’s type in patients stabilized on 10 mg of donepezil hydrochloride once daily.
1 2 0
Total Other Developers 6
Drugs with Suitability No
10MG;14MG ** ** Up - -
10MG;28MG ** ** Up - -
10MG;7MG ** ** Up - -
10MG;21MG ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.